EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study

BACKGROUND/AIMS: The novel prostaglandin E (EP) 3 and prostaglandin F (FP) receptor agonist ONO-9054 is effective in lowering intraocular pressure (IOP) in patients with ocular hypertension and open-angle glaucoma when administered once daily. This study compares the effects of morning (AM) versus e...

Descripción completa

Detalles Bibliográficos
Autores principales: Berlin, Michael S, Rowe-Rendleman, Cheryl, Ahmed, Ike, Ross, Douglas T, Fujii, Akifumi, Ouchi, Takafumi, Quach, Christine, Wood, Andrew, Ward, Caroline L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893083/
https://www.ncbi.nlm.nih.gov/pubmed/26453641
http://dx.doi.org/10.1136/bjophthalmol-2015-307000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893083/
https://www.ncbi.nlm.nih.gov/pubmed/26453641
http://dx.doi.org/10.1136/bjophthalmol-2015-307000

Ejemplares similares